1. A4.07 IL-22 impact on human bone marrow mesenchymal stem cells functions; a unique pathway that may contribute to aberrant new bone formation in human SPA. (24th February 2016) Authors: El-Sherbiny, YM; El-Zayadi, A; Cuthbert, R; Baboolal, T; Fragkakis, A; Jones, E; McGonagle, D Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A9.05 Distinct subsets of interferon-stimulated genes are associated with incomplete and established systemic lupus erythematosus. (24th February 2016) Authors: Psarras, A; Md Yusof, MY; El-Sherbiny, YM; Hensor, EM; Wittmann, M; Emery, P; Vital, EM Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A9.06 Analysis of cell-specific interferon response in systemic lupus erythematosus using a novel flow cytometric assay. (24th February 2016) Authors: El-Sherbiny, YM; Yusof, MY Md; Hensor, EM; Psarras, A; Mohamed, A; Wittmann, M; Emery, P; Vital, EM Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0235 A novel B cell specific IFN-I biomarker is associated with plasmablast numbers following B cell depletion therapy in SLE. (15th June 2017) Authors: El-Sherbiny, YM; Yusof, MY Md; Hensor, E; Rawstron, A; Wittmann, M; Emery, P; Vital, EM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0007 Group 3 innate lymphoid cells numbers in peripheral blood predict ustekinumab (STELARA) therapy responsiveness in psoriatic disease cases with subclinical imaging enthesopathy. (15th June 2017) Authors: El-Sherbiny, YM; Savage, L; Wittmann, M; Emery, P; Goodfield, M; McGonagle, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0251 Predicting and managing primary and secondary non-response to rituximab using b-cell biomarkers in systemic lupus erythematosus. (15th June 2017) Authors: Yusof, MY Md; Shaw, D; El-Sherbiny, YM; Rawstron, AC; Emery, P; Vital, EM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0293 B-cell responses to type I interferon define disease activity in SLE and can be measured by cell surface tetherin (CD317). (15th June 2017) Authors: El-Sherbiny, YM; Yusof, MY Md; Psarras, A; Hensor, E; Tooze, R; Doody, G; Wittmann, M; Emery, P; Vital, EM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗